ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Research Reagent/Mc-MMAD
C51H77N7O9S
964.3 g/mol
Research Reagent

Mc-MMAD

CAS1401963-15-2
Category
Research Reagent
Compound Class
Peptide
Primary Use
Research Compound

Mc-MMAD is a research compound designed as a payload for antibody-drug conjugates. Its structure features multiple amide bonds, aromatic rings, and a maleimide group for site-specific conjugation to antibodies, enabling targeted delivery in experimental settings.

antibody-drug conjugate payload for targeted researchmaleimide-based conjugation linkerlaboratory reagent for bioconjugation studies

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing Mc-MMAD?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

SimilarStructure SimilarSimilarity 0.80

Mafodotin

CAS863971-19-1

pharmaceutical raw material

SimilarStructure SimilarSimilarity 0.80

Dolastatin 10

CAS110417-88-4

pharmaceutical raw material

SimilarStructure SimilarSimilarity 0.75

Monomethylauristatin D

CAS203849-91-6

pharmaceutical raw material

SimilarStructure SimilarSimilarity 0.75

Mc-MMAE

CAS863971-24-8

pharmaceutical raw material

ReferenceSame Category

Aflatoxins

CAS1402-68-2

research compound

ReferenceSame Category

Ferric acetylacetonate

CAS14024-18-1

research compound

ReferenceSame Category

Zinc acetylacetonate

CAS14024-63-6

research compound

ReferenceSame Category

Dibromobis(pyridine)nickel

CAS14024-85-2

research compound

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more
Identifiers
IUPAC Name

6-(2,5-dioxopyrrol-1-yl)-N-[(2S)-1-[[(2S)-1-[[(3R,4S,5S)-3-methoxy-1-[(2S)-2-[(1R,2R)-1-methoxy-2-methyl-3-oxo-3-[[(1S)-2-phenyl-1-(1,3-thiazol-2-yl)ethyl]amino]propyl]pyrrolidin-1-yl]-5-methyl-1-oxoheptan-4-yl]-methylamino]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-N-methylhexanamide

InChIKey

OZUQLKHIIRUJRZ-PGBUMTRMSA-N

SMILES

CC[C@H](C)[C@@H]([C@@H](CC(=O)N1CCC[C@H]1[C@@H]([C@@H](C)C(=O)N[C@@H](CC2=CC=CC=C2)C3=NC=CS3)OC)OC)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)N(C)C(=O)CCCCCN4C(=O)C=CC4=O

Synonyms (3)
  • Mc-MMAD

Sourcing Mc-MMAD?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→